| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390) | Nuvation Bio Inc. | 2022-03-29 |
| Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma (NCT04331041) | Washington University School of Medicine | 2021-08-24 |
| Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients (NCT04536077) | Washington University School of Medicine | 2021-08-13 |
| Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition (NCT04542291) | Washington University School of Medicine | 2021-02-25 |
| Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy (NCT03956056) | Washington University School of Medicine | 2020-02-13 |
| A Pilot Study of BXCL701 in Patients With Pancreatic Cancer (NCT04123574) | BioXcel Therapeutics Inc | 2019-10-15 |
| Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy (NCT03883919) | Washington University School of Medicine | 2019-07-11 |
| Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction (NCT03821025) | University of Cape Town | 2019-01-01 |
| A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) (NCT02905578) | University of Iowa | 2018-11-28 |
| Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy (NCT03122106) | Washington University School of Medicine | 2018-01-05 |
| CAR T Cell Immunotherapy for Pancreatic Cancer (NCT03323944) | University of Pennsylvania | 2017-09-15 |
| Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies (NCT02950025) | Washington University School of Medicine | 2017-01-19 |
| MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors (NCT02669914) | Washington University School of Medicine | 2016-09-12 |
| Epidural Analgesia Use in Pancreatic Resections (NCT02681796) | Washington University School of Medicine | 2016-06-07 |
| BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer (NCT02608229) | Washington University School of Medicine | 2016-06-06 |
| Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma (NCT02352831) | Washington University School of Medicine | 2015-08-31 |
| Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer (NCT02311361) | National Cancer Institute (NCI) | 2015-03-25 |
| A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas (NCT01838317) | University of Texas Southwestern Medical Center | 2013-05-01 |
| Gemcitabine and CT-011 for Resected Pancreatic Cancer (NCT01313416) | Augusta University | 2012-09-01 |
| Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy (NCT02830620) | Centre Hospitalier Universitaire de Nice | 2012-08-01 |
| Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer (NCT01446458) | Emory University | 2011-11-01 |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas (NCT01231347) | NantCell, Inc. | 2011-04-07 |
| Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint (NCT00613730) | Amgen | 2007-01-01 |